Ken Gall, PhD
Chairman of the Board, Entrepreneur
Professor Gall is currently the Associate Dean of Entrepreneurship and Professor of Mechanical Engineering and Materials Science at Duke University. His expertise is in the mechanical behavior of materials with emphasis on the creation, modification, understanding, and commercialization of synthetic biomaterials. His publications have been cited over 21,000 times with an H-index of 77. He is a founder and director of several active medical device start-ups (Restor3d, Pressio Spine, Huxley, DeepBlue, and Penderia). He is also a Director of several other early stage medical device companies (InnAVasc, Sparta, and Orthobond). He was a founder and board member of two medical device startups, MedShape and Vertera, that have been acquired by public strategics for a combined total of $215M on $18M in combined annualized sales. MedShape was acquired through two different exits, the sports medicine division was acquired by Conmed (NASDAQ:CNMD) and the foot and ankle division was acquired by Colfax-DJO (NASDAQ:CFX). Vertera was acquired by Nuvasive (NASDAQ:NUVA).